GlassScriptPhysician profile
Mark D Prince
NPI 1629061171
$4,843.34
in general payments reported to CMS, 2019-2025
9 companies · $2,495 in 2025
The $2,495 reported for 2025 was more than what 84% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $1,268 · 2021: $31.84 · 2022: $40.93 · 2023: $50.40 · 2024: $516 · 2025: $2,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,944 · Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,944.43 |
| Food and Beverage | $1,116.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,429.65 | 2023-2025 | Orise, Resolution 360 Ultra Clip, Spyglass |
| US Endoscopy | $1,500.00 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $244.30 | 2024 | Iqirvo |
| Apollo Endosurgery US INC | $192.75 | 2019-2021 | |
| Micro-Tech Endoscopy USA, INC. | $148.77 | 2025 | |
| Abbvie INC. | $140.57 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $111.26 | 2024 | Stelara, Tremfya |
| Medtronic, INC. | $56.42 | 2025 | Pillcam |
| Qol Medical, LLC | $19.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Prince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.